A multiple regression model to explain the cost of brand-drugs

► Prices are affected by observable factors previously not explored. ► Dosing levels and years since FDA approval contribute to the price of a brand drug. ► Certain condition characteristics are priced higher than others. ► There are differences in manufacturers' price-setting decisions.